OPEN INNOVATION CHALLENGE TO BIOPHARMACEUTICAL ENTREPRENEURS WORLDWIDE! Here is the KEY FACT: Only less than 2% of the potentially druggable sites on the human genome have been exploited. This is THE BOTTLENECK in unlocking the power of medicines to treat diseases. Can you devise a Paradigm Shift to be the next Disruptive Technology in pharmaceuticals? We need a new way of thinking.
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022